...
首页> 外文期刊>Xenobiotica: the fate of foreign compounds in biological systems >Effect of interferon-alpha2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.
【24h】

Effect of interferon-alpha2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.

机译:干扰素-α2b对新鲜制备的人原代肝细胞共培养物中各种药物代谢酶和转运蛋白表达的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to assess the impact of interferon-alpha2b (IFN-alpha2b) on the expression of various drug-metabolizing enzymes and transporters in freshly prepared co-cultures (parenchymal and non-parenchymal cells) of human primary hepatocytes. At therapeutically relevant concentrations (from 1000 to 3000 IU/mL), IFN-alpha2b up-regulated STAT1 (signal transducer and activator of transcription factor 1) mRNA expression. Conversely, three cytochrome P450s (CYP1A2, CYP2B6, CYP2E1), a UDP-glucuronosyltransferase (UGT2B7), a sulphotransferase (SULT1A1) and organic anion transporter (OAT2) were significantly down-regulated (~50%; P < 0.05). Western blot analysis of CYP1A2, UGT2B7 and OAT2 protein supported the mRNA data. Two peroxisome proliferator activator receptor alpha (PPARalpha)-controlled genes (pyruvate dehydrogenase kinase 4 and adipose differentiation-related protein), CYP3A4 and multidrug resistance-associated protein 2 were significantly up-regulated (up to 223%; P < 0.05). On the other hand, SULT2A1, carboxylesterase 2, organic anion transporting peptide (OATP1B1, OATP1B3, OATP2B1), organic cation transporter 1, P-glycoprotein and breast cancer resistance protein mRNA expression was not significantly affected. Western blot analysis of CYP3A4 supported the mRNA data also. The present results demonstrated complex interactions between IFN-alpha2b and hepatocytes and the observed down-regulation of CYP1A2, OAT2 and UGT2B7 is consistent with reports of drug interactions between IFN-alpha2b and drugs such as theophylline, clozapine and gemfibrozil.
机译:这项研究的目的是评估干扰素-α2b(IFN-α2b)对人原代肝细胞新鲜制备的共培养物(实质和非实质细胞)中各种药物代谢酶和转运蛋白表达的影响。在治疗相关浓度(1000至3000 IU / mL)下,IFN-alpha2b上调STAT1(信号转导子和转录因子1的激活子)的mRNA表达。相反,三种细胞色素P450(CYP1A2,CYP2B6,CYP2E1),UDP-葡萄糖醛酸糖基转移酶(UGT2B7),磺基转移酶(SULT1A1)和有机阴离子转运蛋白(OAT2)均显着下调(〜50%; P <0.05)。 CYP1A2,UGT2B7和OAT2蛋白的蛋白质印迹分析支持mRNA数据。 CYP3A4和多药耐药相关蛋白2被两个过氧化物酶体增殖物激活剂受体α(PPARalpha)控制的基因(丙酮酸脱氢酶激酶4和脂肪分化相关蛋白)显着上调(最高223%; P <0.05)。另一方面,SULT2A1,羧酸酯酶2,有机阴离子转运肽(OATP1B1,OATP1B3,OATP2B1),有机阳离子转运蛋白1,P-糖蛋白和乳腺癌抗性蛋白的mRNA表达没有受到显着影响。 CYP3A4的蛋白质印迹分析也支持mRNA数据。目前的结果表明,IFN-α2b与肝细胞之间存在复杂的相互作用,并且所观察到的CYP1A2,OAT2和UGT2B7的下调与IFN-α2b与诸如茶碱,氯氮平和吉非贝齐等药物之间相互作用的报道一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号